New rheumatoid arthritis drug targets NIH-discovered protein National Institutes of Health (press release) In 1993, shortly after O'Shea and his team discovered the JAK3 protein and established its role in inflammation, O'Shea learned that scientists at Pfizer were searching for drug targets to tackle autoimmunity and transplant rejection. Subsequent ... |
